LakeShore Biopharma

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	70.10 k	70.10 k	70.10 k	70.10 k	70.10 k	70.10 k
Cash burn (monthly)	181.95 k	83.75 k	193.73 k	127.32 k	1.93 mm	944.86 k
Cash used (since last report)	4.87 mm	2.24 mm	5.19 mm	3.41 mm	51.74 mm	25.31 mm
Cash remaining	-4.80 mm	-2.17 mm	-5.12 mm	-3.34 mm	-51.67 mm	-25.24 mm
Runway (months of cash)	-26.4	-26.0	-26.4	-26.2	-26.8	-26.7

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q1 2023

LakeShore Biopharma institutional ownership history Ownership history

37.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	3	30	-90.0%
Opened positions	0	10	EXIT
Closed positions	27	18	+50.0%
Increased positions	0	4	EXIT
Reduced positions	0	13	EXIT

13F shares	Current	Prev Q	Change
Total value	0.00	18.07 bn	EXIT
Total shares	7.45 mm	15.77 mm	-52.8%
Total puts	0.00	0.00
Total calls	0.00	1.08 mm	EXIT
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Summit Healthcare Acquisition Sponsor	5.30 mm	$0.00	0.0%
Integrated Core Strategies	1.13 mm	$0.00	0.0%
Fitzgerald Securities Cantor	1.03 mm	$0.00	0.0%

Largest transactions	Bought/sold	Change
Glazer Capital	-1.74 mm	EXIT
Aristeia Capital	-1.61 mm	EXIT
LMR Partners	-1.04 mm	EXIT
Segantii Capital Management	-600.00 k	EXIT
BFAM Partners	-550.00 k	EXIT
Snow Lake Capital	-500.00 k	EXIT
Finepoint Capital	-490.00 k	EXIT
Periscope Capital	-247.90 k	EXIT
Ovata Capital Management	-150.00 k	EXIT
Athos Capital	-150.00 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.